FDA warns against use of certain OTC eye drop products
HQ Team October 31, 2023: The US Food and Drug Administration has warned consumers not to use certain over-the-counter eye drop products due.
Drugs
Health
Pharma
Drugs
Medical
Pharma
Novartis sells eye business to Bausch+Lomb for $2.5 billion
HQ Team July 3, 2023: Swiss drugmaker Novartis is divesting its ophthalmology assets including Xiidra, an anti-inflammatory eye drop to Bausch + Lomb,.